Internal Medicine, Medical Oncology · New York, NY
NPI
1508023870
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave
New York, NY, 10065
Phone (212) 639-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
633 services
Medicare patients, 2024
181
Average age 75
Drug cost, 2024
$2.7M
886 prescriptions
Company payments, 2025
$42K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul Paik was code 99214 (office e&m - established), 255 times for 83 patients. In total Paul Paik billed 633 services in 11 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 255 | 83 | $80.42 | $21K |
| 99215 Office E&M - Established | Office | 189 | 58 | $124.85 | $24K |
| 99213 Office E&M - Established | Office | 75 | 56 | $65.19 | $4,889 |
| 99205 Office E&M - New | Office | 54 | 54 | $154.43 | $8,339 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 12 | $103.21 | $3,406 |
By year: 2022 $70K for 739 services; 2023 $74K for 728 services; 2024 $63K for 633 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul Paik prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 96 prescriptions and refills. In total Paul Paik wrote 886 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 96 | 96 | 13 | $1.6M |
| Dexamethasone Generic | 89 | 89 | 31 | $1,069 |
| Prednisone Generic | 77 | 79 | 30 | $310 |
| Olanzapine Generic | 41 | 47 | Under 11 | $571 |
| Ondansetron Hcl Generic | 39 | 39 | 19 | $421 |
| Amlodipine Besylate Generic | 38 | 48 | Under 11 | $286 |
| Erlotinib Hcl Generic | 25 | 25 | Under 11 | $51K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 22 | 22 | Under 11 | $667 |
| Oxycodone Hcl Generic | 19 | 19 | 12 | $287 |
| Alclometasone Dipropionate Generic | 17 | 19 | Under 11 | $882 |
| Alecensa Alectinib Hcl | 17 | 17 | Under 11 | $322K |
| Hydrochlorothiazide Generic | 16 | 16 | Under 11 | $101 |
| Prochlorperazine Maleate Generic | 16 | 16 | 11 | $417 |
| Folic Acid Generic | 15 | 15 | Under 11 | $35.69 |
| Zolpidem Tartrate Generic | 14 | 14 | Under 11 | $52.52 |
Brand drugs: - claims; generic drugs: 660 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul Paik $42K ($42K in general payments such as food, travel and fees) from 8 companies. The largest payer was EMD Serono, Inc. with $33K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.